Cortexyme (CRTX) small-cap bio with a big insider buy last week from director David Lamond of 49,125 shares at $43.27, a more than $2.1M investment. Shares are down 25% in 2020 but up over 65% in the last twelve months, a volatile name with ATR of ar...